The Bredesen Protocol, developed by neurologist Dr Dale Bredesen, is a structured, personalised framework designed to help you understand their cognitive risks and take targeted steps to support long‑term brain health. It is used internationally and is now available in Australia through trained practitioners and certified health coaches including through Cognevity.

A clinical trial from Harvard Medical School and the McCance Center for Brain Health with Dean Ornish, published on 7 June 2024 in Alzheimer’s Research & Therapy, validates that targeted lifestyle changes can lead to measurable improvements in cognitive function - in early-stage Alzheimer’s disease or mild cognitive impairment (MCI).

Initiated in 2009, the Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER) is widely recognized as one of the first large-scale research efforts to break new ground at the time to explore how lifestyle interventions can serve as a preventative measure against cognitive decline.

I often get asked about the difference between Alzheimer's and dementia. Dementia is the ‘Umbrella’ term for a range of different neurological conditions that cause cognitive decline, including Alzheimer's disease. Alzheimer’s is the most common type of dementia accounting for approximately 60-70% of all cases.